Clinical trial · Observational
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
NCT06309836CI-TRIAL-00090937REGISTRO-BCCrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- clinical evolution, treatment and prognosis
- timeFrame
- from baseline through study completion, an average of 3 years
- description
- clinical profile of patient, the phenotypic and behavioural characteristic and the clinical course from baseline to follow-up.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male and female patients aged ≥ 18 years 2. Patients diagnosed with advanced basal cell carcinoma of the skin, i.e. tumours included in at least one of the following categories: locally advanced carcinoma (not radically treatable by surgery and/or radiotherapy), carcinoma with lymph node and/or distant metastatic localisation 3. patients who have had at least one access (first visit or follow-up visit) at the dermatology or oncology outpatient clinic of the centres involved * Patients diagnosed with advanced BCC who have accessed the centre from 1 January 2016 until the date of activation of the centre will be included in the retrospective cohort; * Patients diagnosed with advanced BCC who have accessed the centre from the date of activation 4. Signature of informed consent Exclusion Criteria: Patients incapable of giving informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.